CPAP Criteria for OSA
CPAP therapy should be initiated in adults with moderate-to-severe OSA (AHI ≥15 events/hour) as first-line treatment, and may be considered for mild OSA (AHI 5-14 events/hour) when patients have significant symptoms like excessive daytime sleepiness, cardiovascular/cerebrovascular disease, hypertension, diabetes, or cognitive impairment. 1, 2
Severity-Based Indications
Strong Indications (Moderate-to-Severe OSA)
- AHI ≥15 events/hour - CPAP is the standard first-line therapy regardless of symptom presence 1, 2
- This represents a strong recommendation based on moderate-quality evidence demonstrating improvements in sleepiness, quality of life, and blood pressure 1
Conditional Indications (Mild OSA)
CPAP may be initiated for AHI 5-14 events/hour when ANY of the following are present:
- Excessive daytime sleepiness (ESS >10)
- Cardiovascular or cerebrovascular disease
- Hypertension (particularly resistant hypertension)
- Type 2 diabetes mellitus
- COPD
- Cognitive impairment, insomnia, or depression
- Perioperative patients (especially bariatric surgery candidates) 2
Diagnostic Requirements Before CPAP
OSA diagnosis must be established by objective sleep testing - either:
- Polysomnography (PSG) - gold standard, preferred for complex cases, comorbid sleep disorders, and high-risk occupations 2
- Home Sleep Apnea Testing (HSAT) - acceptable for clinically suspected moderate-to-severe uncomplicated OSA, but cannot rule out OSA 2
Questionnaires alone (STOP-Bang, Berlin, ESS) are insufficient for diagnosis and should not replace objective testing 3
Special Population Considerations
Non-Sleepy Patients with Comorbid Hypertension
CPAP is recommended for non-sleepy OSA patients with hypertension based on clinically significant blood pressure reductions:
- Nocturnal systolic BP: largest reductions
- 24-hour systolic/diastolic BP: moderate reductions
- Greatest benefit in resistant hypertension and moderate-to-severe OSA 1
Non-Sleepy Patients Without Hypertension
Insufficient evidence exists to recommend CPAP solely for cardiovascular event or mortality reduction in non-sleepy patients without hypertension. Meta-analyses of RCTs showed no significant improvements in CV events or mortality, despite observational data suggesting benefit 1
For these patients, consider a three-step phenotyping approach:
- Assess for OSA symptoms beyond sleepiness (morning headaches, nocturia, cognitive impairment, mood changes)
- Evaluate cardiovascular risk factors and comorbidities
- Consider OSA severity markers (nocturnal hypoxemia burden, arousal index) 4
CPAP Titration Requirements
Pressure Titration Protocol
Starting pressure: 4 cm H₂O minimum for all adults 3
Maximum pressure: 20 cm H₂O for adults ≥12 years 3
Pressure increases:
- Increase by ≥1 cm H₂O increments
- Wait minimum 5 minutes between increases
- Increase for: ≥2 obstructive apneas, ≥1 hypopnea, ≥3 RERAs, or ≥3 minutes of loud snoring 3
Titration Methods (in order of preference)
- Full-night attended in-laboratory PSG - gold standard 3
- Split-night study - acceptable for moderate-to-severe OSA (diagnostic portion shows AHI ≥15, then titrate remainder of night) 3
- Home auto-titration (APAP) - acceptable for uncomplicated moderate-to-severe OSA 1, 2
Manual titration is preferred over auto-titration when:
- Congestive heart failure present
- Severe pulmonary disease
- Neuromuscular disease
- Prior uvulopalatopharyngoplasty
- Need for supplemental oxygen
- Expected desaturation from non-OSA causes (hypoventilation, central sleep apnea) 2
When to Switch from CPAP to BiPAP
Switch to BiPAP if:
- Obstructive events persist at CPAP ≥15 cm H₂O during titration 3
- Patient intolerant of high CPAP pressures 3
- OSA with chronic hypoventilation (COPD, neuromuscular disease, obesity hypoventilation syndrome) 2
Common Pitfalls
Do not:
- Diagnose OSA based on questionnaires alone - objective testing is mandatory 3
- Use HSAT to rule out OSA - it can only confirm moderate-to-severe disease 2
- Withhold CPAP from non-sleepy patients with hypertension - BP benefits are established 1
- Increase CPAP by >2.5 cm H₂O increments - insufficient evidence for larger jumps 3
Do:
- Screen high-risk populations systematically (obesity, hypertension, diabetes, cardiovascular disease) 2
- Provide education, mask fitting, and acclimatization before titration 3
- Monitor adherence objectively and follow up at 1 week, 1 month, 3 months, then every 6-12 months 2, 5
- Consider heated humidification to improve adherence 5